Dr. Reddy’s Posts $1.747 Billion in Revenue for Six-Month Period Ended Sept. 30

Dr. Reddy’s Laboratories Ltd. released Oct. 23 interim results for the six months ended Sept. 30, 2026, posting $1.747 billion in revenue and diluted EPS of $0.17. For the second quarter alone, revenue was $905 million and diluted EPS was $0.12. The interim statements use International Financial Reporting Standards (IFRS); the U.S. dollar amounts are convenience translations. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Source: TokenPost